Zareini, Bochra http://orcid.org/0000-0002-3891-5957
Sørensen, Katrine Kold
Blanche, Paul
Falkentoft, Alexander C.
Fosbøl, Emil
Køber, Lars
Torp-Pedersen, Christian
Funding for this research was provided by:
Royal Library, Copenhagen University Library
Article History
Received: 23 June 2023
Accepted: 14 September 2023
First Online: 10 October 2023
Declarations
:
: Christian Torp-Pedersen reports grants from Bayer and Novo Nordisk unrelated to the current study. Ulrik Pedersen-Bjergaard has served on advisory boards for Novo Nordisk, Sanofi, and Vertex and has received lecture fees from Novo Nordisk and Sanofi. Lars Køber reports speakers’ honorariums from AstraZeneca, Bayer, Boehringer, Novartis, and Novo. Emil Fosbøl is the recipient of the independent research funding for valvular heart disease from the Novo Nordisk Foundation. All other authors declare no competing interests.